BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/5/2026 3:26:24 AM | Browse: 4 | Download: 0
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Metformin fails to prevent diabetes in non-diabetic cardiovascular patients: Systematic review and meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Georgios Ι Tsironikos, George Ε Zakynthinos, Despoina Kyprianidou, Vasiliki Rammou, Thomas Antonogiannis, Alexandra Bargiota, Epaminondas Zakynthinos and Vasiliki Tsolaki |
| Funding Agency and Grant Number |
|
| Corresponding Author |
George Ε Zakynthinos, MD, 3rd Department of Cardiology, "Sotiria" Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, Mesogion 152, Athens 11527, Greece. gzakynthinos2@gmail.com |
| Key Words |
Metformin; Cardiovascular disease; Coronary artery disease; New onset type 2 diabetes mellitus; Diabetes prevention; Glucagon-like-peptide-1 receptor agonists; Sodium-glucose cotransporter 2 inhibitors; RCTs |
| Core Tip |
This meta-analysis evaluated the role of metformin in preventing type 2 diabetes among non-diabetic patients with coronary artery disease. Across 933 participants from randomized controlled trials, metformin did not significantly reduce the incidence of diabetes compared to control. The findings were consistent across multiple subgroup analyses, including variations in age, gender, comorbidities, dosage, and follow-up duration. Despite low heterogeneity, the overall quality of evidence was very low, limiting the strength of conclusions. These results suggest that metformin should not be routinely used for diabetes prevention in non-diabetic coronary artery disease patients until more robust evidence from larger trials becomes available. |
| Citation |
Tsironikos GI, Zakynthinos GE, Kyprianidou D, Rammou V, Antonogiannis T, Bargiota A, Zakynthinos E, Tsolaki V. Metformin fails to prevent diabetes in non-diabetic cardiovascular patients: Systematic review and meta-analysis. World J Cardiol 2026; In press |
 |
Received |
|
2025-10-24 03:08 |
 |
Peer-Review Started |
|
2025-10-24 03:08 |
 |
First Decision by Editorial Office Director |
|
2025-11-19 10:09 |
 |
Return for Revision |
|
2025-11-19 10:09 |
 |
Revised |
|
2025-12-02 16:12 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-02-05 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-02-05 03:26 |
 |
Articles in Press |
|
2026-02-05 03:26 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345